Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Current Medicinal Chemistry|December 15, 2023
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled TrialsBehrooz Heydari, Adeleh Sahebnasagh, Mohammad Ali Omrani, et al.BMC Infectious Diseases|March 25, 2021
Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trialAmirreza Roostaei Firozabad, Zohreh Akhoundi Meybodi, Seyed Ruhollah Mousavinasab, et al.Journal of Pharmaceutical and Biomedical Analysis|November 17, 2023
Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancerFatemeh Saghafi, Ebrahim Salehifar, Pouneh Ebrahimi, et al.European Journal of Pharmacology|September 4, 2020
The prophylaxis and treatment potential of supplements for COVID-19Adeleh Sahebnasagh, Fatemeh Saghafi, Razieh Avan, et al.European Journal of Medical Research|March 2, 2023
Prevention of radiotherapy-related oral mucositis with zinc and polyherbal mouthwash: a double-blind, randomized clinical trialMarzieh Sahebnasagh, Vahideh Aksi, Fatemeh Eslami, et al.Journal of Clinical Pharmacy and Therapeutics|August 30, 2020
Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19Adeleh Sahebnasagh, Fatemeh Saghafi, Mohammadreza Safdari, et al.Archives of Medical Research|September 1, 2020
A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19Adeleh Sahebnasagh, Mojataba Mojtahedzadeh, Farhad Najmeddin, et al.Caspian Journal of Internal Medicine|March 8, 2021
Efficacy of sucralfate ointment in the prevention of acute proctitis in cancer patients: A randomized controlled clinical trialSara Saei, Adeleh Sahebnasagh, Arash Ghasemi, et al.Journal of Intensive Care|July 30, 2022
Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDSShahideh Amini, Aysa Rezabakhsh, Javad Hashemi, et al.Biochimie|August 18, 2020
Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon?Razieh Dowran, Seyed Fazel Nabavi, Solomon Habtemariam, et al.Pageof 6